Your browser doesn't support javascript.
loading
Relationship between intrapartum antibiotic prophylaxis and group B streptococcal colonization dynamics in Japanese mother-neonate pairs.
Shibata, Meiwa; Morozumi, Miyuki; Maeda, Naonori; Komiyama, Osamu; Shiro, Hiroyuki; Iwata, Satoshi; Ubukata, Kimiko.
Afiliação
  • Shibata M; Department of Pediatrics, Yokohama Rosai Hospital, Japan; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Morozumi M; Department of Infectious Diseases, Keio University School of Medicine, Japan.
  • Maeda N; Department of Pediatrics, National Hospital Organization Tokyo Medical Center, Japan.
  • Komiyama O; Department of Pediatrics, National Hospital Organization Tokyo Medical Center, Japan.
  • Shiro H; Department of Pediatrics, Yokohama Rosai Hospital, Japan.
  • Iwata S; Department of Infectious Diseases, Keio University School of Medicine, Japan; Department of Infectious Diseases, National Cancer Center Hospital, Japan.
  • Ubukata K; Department of Infectious Diseases, Keio University School of Medicine, Japan; Department of General Medicine, Keio University School of Medicine, Japan. Electronic address: ubukatak@keio.jp.
J Infect Chemother ; 27(7): 977-983, 2021 Jul.
Article em En | MEDLINE | ID: mdl-33610482
INTRODUCTION: In Japan, universal screening for group B streptococcal (GBS) colonization in pregnant women and intrapartum antibiotic prophylaxis (IAP) are recommended to prevent neonatal GBS infection. However, the dynamics of GBS colonization in Japanese mother/neonate pairs have not been adequately studied. METHODS: A prospective cohort study was conducted from July 2018 to March 2019. Rectovaginal samples were collected from pregnant women (33-37 gestation weeks) once. In neonates, nasopharyngeal and rectal samples were collected at three time points: after birth, 1 week after birth, and 1 month after birth. All samples were analyzed for GBS using real-time PCR testing and culture methods. Capsular typing was performed for all GBS isolates and GBS-positive samples using real-time PCR testing. RESULTS: The overall maternal and neonatal GBS-positivity rates were 22.7% (57/251) and 8.8% (22/251), respectively. IAP for GBS-positive mothers (96.5%) was highly administered. Eleven (19.3%) neonates born to GBS-positive mothers were GBS-positive, which was significantly higher than the 11 (5.7%) neonates born to GBS-negative mothers. The rate of GBS-positivity in neonates increased with an increased number of GBS colonies in mothers. More neonates were GBS-positive 1 month after birth than 1 week after birth, and there was a higher rate of GBS-positive rectal swabs than nasopharyngeal swabs. Capsular types of GBS that were isolated from each mother and neonate pair were the same, namely, Ib, III, V, and VI. CONCLUSIONS: These findings indicate that the efficacy of IAP in preventing GBS transmission to neonates might be limited to within a few weeks after birth.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Infecções Estreptocócicas Tipo de estudo: Observational_studies Limite: Female / Humans / Newborn / Pregnancy País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Complicações Infecciosas na Gravidez / Infecções Estreptocócicas Tipo de estudo: Observational_studies Limite: Female / Humans / Newborn / Pregnancy País/Região como assunto: Asia Idioma: En Ano de publicação: 2021 Tipo de documento: Article